Equitable Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,138
Closed -$211K 491
2024
Q3
$211K Buy
+2,138
New +$210K 0.01% 433
2024
Q2
Sell
-2,138
Closed -$203K 452
2024
Q1
$203K Buy
+2,138
New +$198K 0.01% 418
2023
Q1
Sell
-2,467
Closed -$205K 411
2022
Q4
$205K Sell
2,467
-18,101
-88% -$1.47M 0.02% 377
2022
Q3
$1.63M Sell
20,568
-277
-1% -$23.4K 0.14% 135
2022
Q2
$1.55M Sell
20,845
-87,474
-81% -$6.57M 0.12% 146
2022
Q1
$9.73M Buy
108,319
+105,728
+4,081% +$9.76M 0.63% 39
2021
Q4
$290K Sell
2,591
-1,446
-36% -$174K 0.02% 321
2021
Q3
$507K Hold
4,037
0.03% 241
2021
Q2
$547K Sell
4,037
-577
-13% -$75.9K 0.04% 238
2021
Q1
$626K Hold
4,614
0.05% 218
2020
Q4
$650K Buy
4,614
+83
+2% +$10.6K 0.05% 225
2020
Q3
$505K Buy
4,531
+500
+12% +$56.1K 0.04% 233
2020
Q2
$451K Buy
4,031
+205
+5% +$20.2K 0.04% 226
2020
Q1
$296K Buy
3,826
+35
+0.9% +$3.1K 0.03% 255
2019
Q4
$361K Sell
3,791
-418
-10% -$36.2K 0.04% 226
2019
Q3
$321K Sell
4,209
-70
-2% -$5.82K 0.03% 233
2019
Q2
$375K Sell
4,279
-696
-14% -$59.4K 0.04% 214
2019
Q1
$450K Sell
4,975
-146
-3% -$12.4K 0.05% 204
2018
Q4
$367K Buy
5,121
+129
+3% +$10.4K 0.05% 204
2018
Q3
$479K Sell
4,992
-200
-4% -$19.4K 0.06% 206
2018
Q2
$494K Buy
+5,192
New +$477K 0.06% 187

Other funds holding XBI

Equitable Trust's XBI Position: Q4 2024 in Review

Equitable Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 2,138 shares — an estimated $211K sold.

Equitable Trust first reported a position in XBI in Q2 2018 and held it in 21 quarters. The position peaked at $9.73M in Q1 2022. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Equitable Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Equitable Trust sold 2,138 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $211K.
  • Equitable Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 21 quarters.
  • Equitable Trust's State Street SPDR S&P Biotech ETF position peaked at $9.73M in Q1 2022.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Equitable Trust's 13F filing for Q4 2024, filed 28 Jan 2025.